β-phenylglutamic acid | 57746-22-2

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: β-phenylglutamic acid
• 英文别名: 2-amino-3-phenyl-glutaric acid；2-Amino-3-phenyl-glutarsaeure；α-Amino-β-phenyl-glutarsaeure；β-Phenyl-glutaminsaeure；2-amino-3-phenylpentanedioic acid；3-phenylglutamic acid
• CAS: 57746-22-2
• 化学式: C₁₁H₁₃NO₄
• 分子量: 223.229
• InChiKey: UXEDFOHTFRNIJS-UHFFFAOYSA-N

物化性质

• 熔点：
  228-231 °C (decomp)
• 沸点：
  388.6±42.0 °C(Predicted)
• 密度：
  1.346±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -2.1
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  101
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  β-phenylglutamic acid 在 水 作用下， 生成 4-phenyl-5-carboxy-2-pyrrolidinone
  参考文献：
  名称：

  Harington, Journal of Biological Chemistry, 1925, vol. 64, p. 33

  摘要：

  DOI：
• 作为产物：
  描述：

  2-hydroxyimino-3-phenyl-glutaric acid 在 sodium amalgam 、 水 作用下， 生成 β-phenylglutamic acid
  参考文献：
  名称：

  Harington, Journal of Biological Chemistry, 1925, vol. 64, p. 33

  摘要：

  DOI：

文献信息

• Method and compositions for identifying anti-HIV therapeutic compounds
  申请人：GILEAD SCIENCES, INC.

  公开号：US20040121316A1

  公开（公告）日：2004-06-24

  Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.

  提供了一种鉴定含有羧酸酯或磷酸酯基团抗HIV治疗化合物的方法。可以选择使用新型酶GS-7340酯水解酶筛选这类化合物的文库。还提供了与GS-7340酯水解酶相关的组合物和方法。
• Novel compounds and methods for synthesis and therapy
  申请人：——

  公开号：US20040053999A1

  公开（公告）日：2004-03-18

  Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.

  描述了新化合物。这些化合物通常包括一个酸性基团，一个碱性基团，一个取代氨基或N-酰基和一个具有可选择羟基化的烷基部分的基团。还描述了包括本发明的抑制剂的药物组合物。还描述了在疑似含有神经氨酸酶的样品中抑制神经氨酸酶的方法。还描述了抗原材料、聚合物、抗体、本发明化合物与标记物的结合物以及用于检测神经氨酸酶活性的测定方法。
• Nitrile-containing enzyme inhibitors and ruthenium complexes thereof
  申请人：The Ohio State University Research Foundation

  公开号：US20140100173A1

  公开（公告）日：2014-04-10

  The invention provides nitrile-containing protease inhibitors caged to ruthenium compounds. The nitrile-caged ruthenium compounds provide inactivated inhibitors that can be delivered to surface or site for activation, for example, but exposure to light. The invention also provides methods for delivering protease inhibitors to subjects for the therapeutic treatment of conditions such as cancer.

  这项发明提供了与钌化合物结合的含腈基蛋白酶抑制剂。这些腈基蛋白酶抑制剂与钌化合物结合后形成失活的抑制剂，可以通过光照等方式被释放到表面或部位进行激活。该发明还提供了将蛋白酶抑制剂传递给受试者以治疗癌症等疾病的方法。
• Inhibitors of hepatitis C virus NS3 protease
  申请人：——

  公开号：US20020065248A1

  公开（公告）日：2002-05-30

  The present invention relates to compounds of Formula (I): 1 wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HCV NS3 protease, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.

  本发明涉及化合物的结构公式（I）：其中A1为亚甲基、乙烯基或丙烯基，A2为N或CR5，或其立体异构体形式、立体异构体混合物或药用盐形式，用作HCV NS3蛋白酶的抑制剂，以及包含相同化合物的药物组合物和诊断试剂盒，以及用于治疗病毒感染或作为测定标准或试剂的方法。
• Amino Acid Analogs III: New Syntheses of Monomethyl- and Monophenylglutamic Acids
  作者：Herman Gershon、Raulo Parmegiani、Vincent R. Giannasio、Ira S. Krull

  DOI：10.1002/jps.2600641123

  日期：1975.11

  Glutamic acid analogs containing 3- and 4-methyl and 2-, 3-, and 4-phenyl substituents were prepared. The 3- and 4-methyl- and 3- and 4-phenylglutamic acids did not inhibit Plasmodium berghei and were nontoxic to the host (mice) at 640 mg/kg. The five analogs in addition to 2-methlglutamic acid were inactive against Lactobacillus casei at 1000 mug/ml in a defined medium: against Escherichia coli, only

  制备了含有3-和4-甲基以及2-，3-和4-苯基取代基的谷氨酸类似物。3-和4-甲基-和3-和4-苯基谷氨酸不抑制伯氏疟原虫并且以640 mg / kg的剂量对宿主（小鼠）无毒。除2-甲基谷氨酸外，这五种类似物在规定的培养基中以1000杯/毫升的速率对干酪乳杆菌无活性：对于大肠杆菌，只有2-甲基谷氨酸在10,000杯/毫升的情况下产生27％的抑制作用。在低于10,000杯/毫升的特定培养基中，所有六个类似物均未能抑制黑曲霉，米曲霉，木霉菌和绿霉菌。